Close
Elizabeth Diaz, PA-C
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Elizabeth Diaz, PA-C
Elizabeth Diaz, PA-C, is a nationally certified physician assistant specializing in medical oncology at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. She started her career in pediatrics and family medicine. She joined The University of Texas Health Science Center at San Antonio in 2007 to pursue her interest in cancer research.
She has worked in medical oncology for over 15 years, primarily treating patients with advanced malignancies in the sarcoma and genitourinary clinics. Elizabeth is interested in cancer research and cares for patients in Phase I clinical trials.
She completed her undergraduate training at The University of Texas at Austin and graduated from The University of Texas Medical Branch at Galveston with a bachelor's degree in physician assistant studies.
She is a member of the American Academy of Physician Assistants and the Association of Physician Assistants in Oncology.
Gender
- Female
Languages Spoken
- French
- Spanish
-
Credentials
Credentials
Positions
- Physician Assistant, Division of Hematology and Oncology, University of Texas Health Science Center San Antonio
- Physician Assistant, Sarcoma and Genitourinary Oncology, UT Health San Antonio MD Anderson Cancer Center
Certifications
- The National Commission on Certification of Physician Assistants (NCCPA)
Education
Graduate: The University of Texas Medical Branch at Galveston, Galveston, Texas
Undergraduate: The University of Texas at Austin, Austin, Texas -
Locations & Contact
Locations & Contact
Elizabeth Diaz is a wonderful provider. We have developed a great relationship over the years. She always answers our questions fully and in a way we can understand. She is the best!
Patient
-
Research & Publications
Research & Publications
Partial response of a rare malignant metastatic diffuse tenosynovial giant cell tumor with benign histologic features, treated with SCH 717-454, an insulin growth factor receptor inhibitor, in combination with everolimus, an MTOR inhibitor.
Sikaria, S., Heim-Hall, J., Diaz, E. H., Williams, R., Sankhala, K., Laabs, B. & Mita, M.
Target Oncol. (2013) PMID: 23430345.
Clavulanic Acid Is a Leading Culprit Beta-Lactam in Immediate Allergic Reactions to Penicillins
Torres-Rojas I, Pérez-Alzate D, Somoza ML, Pfeifer AP, Diaz EH, Jimenez-Rodriguez TW, Sánchez JF, Ruano FJ, Blanca M, Blanca-López N.
Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
De Laere B, van Dam PJ, Whitington T, Mayrhofer M, Diaz EH, Van den Eynden G, Vandebroek J, Del-Favero J, Van Laere S, Dirix L, Grönberg H, Lindberg J.
-
Clinical Trials
Clinical Trials
No Clinical Trials